Bioxcel Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $143k | 48k | 2.95 |
| 2023-09-30 | $199k | 79k | 2.53 |
| 2023-06-30 | $739k | 111k | 6.66 |
| 2023-03-31 | $3.0M | 160k | 18.66 |
| 2022-12-31 | $3.0M | 139k | 21.48 |
| 2022-09-30 | $1.7M | 143k | 11.86 |
| 2022-06-30 | $1.5M | 117k | 13.20 |
| 2022-03-31 | $3.8M | 181k | 20.91 |
| 2021-12-31 | $4.1M | 200k | 20.33 |
| 2021-09-30 | $6.5M | 216k | 30.35 |
| 2021-06-30 | $4.7M | 161k | 29.09 |
| 2021-03-31 | $8.5M | 197k | 43.16 |
| 2020-12-31 | $4.2M | 92k | 46.20 |
| 2020-09-30 | $3.8M | 88k | 43.36 |
| 2020-06-30 | $4.3M | 81k | 53.01 |
| 2020-03-31 | $1.9M | 87k | 22.35 |
| 2019-12-31 | $1.4M | 93k | 14.61 |
| 2019-09-30 | $563k | 80k | 7.04 |
| 2019-06-30 | $828k | 76k | 10.96 |
| 2019-03-31 | $745k | 75k | 9.92 |
| 2018-12-31 | $48k | 13k | 3.75 |
| 2018-09-30 | $30k | 3.9k | 7.68 |
| 2018-06-30 | $29k | 3.2k | 9.07 |
| 2018-03-31 | $27k | 2.7k | 10.00 |